Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Buy
3,984
+24
+0.6% +$8.56K 0.66% 41
2025
Q4
$1.3M Buy
3,960
+73
+2% +$23.2K 0.62% 42
2025
Q3
$1.1M Buy
3,887
+6
+0.2% +$1.74K 0.73% 46
2025
Q2
$1.08M Buy
3,881
+58
+2% +$16.4K 0.93% 44
2025
Q1
$1.19M Sell
3,823
-3
-0.1% -$886 1.1% 32
2024
Q4
$997K Buy
+3,826
New +$1.14M 0.98% 40
2023
Q4
$997K Buy
+3,826
New +$1.04M 0.99% 40

Other funds holding AMGN

Croban's AMGN Position: Q1 2026 in Review

Croban increased its Amgen (AMGN) stake by 0.61% in Q1 2026, buying an estimated $8.56K and bringing the position to 3,984 shares worth $1.4M. The position accounts for 0.66% of the portfolio, ranked #41.

Croban first reported a position in AMGN in Q4 2023 and has held it in 7 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Croban held 3,984 shares of Amgen worth $1.4M as of Q1 2026.
  • Croban bought 24 Amgen shares in Q1 2026, an estimated $8.56K.
  • Amgen made up 0.66% of Croban's portfolio in Q1 2026, its #41 holding.
  • Croban first reported a position in Amgen in Q4 2023 and has held it in 7 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Croban's 13F filing for Q1 2026, filed 13 May 2026.